SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001400482-16-000211
Filing Date
2016-08-08
Accepted
2016-08-05 18:59:37
Documents
45
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2016q210-q.htm 10-Q 767046
2 EXHIBIT 31.1 acucela-20160630xexhibit311.htm EX-31.1 11455
3 EXHIBIT 31.2 acucela-20160630xexhibit312.htm EX-31.2 11410
4 EXHIBIT 32.1 acucela-20160630xexhibit321.htm EX-32.1 6290
5 EXHIBIT 32.2 acucela-20160630xexhibit322.htm EX-32.2 6126
  Complete submission text file 0001400482-16-000211.txt   2828725

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acuc-20160630.xml EX-101.INS 425227
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acuc-20160630.xsd EX-101.SCH 23017
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acuc-20160630_cal.xml EX-101.CAL 43610
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acuc-20160630_def.xml EX-101.DEF 80160
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acuc-20160630_lab.xml EX-101.LAB 292827
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acuc-20160630_pre.xml EX-101.PRE 162444
Mailing Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Filer) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55133 | Film No.: 161812293
SIC: 2834 Pharmaceutical Preparations